Fidelity Disruptive Medicine ETF (FMED)

NASDAQ: FMEDExchange-traded fund from Fidelity Investments.

  • Expense ratio0.51%
  • Net assets$51.4M
  • Dividend yield0.00%
  • 1-year return+20.49%
  • Holdings70

FMED ETF price chart

FMED quote & trading statistics

FMED performance

Annual returns & drawdowns →
  • YTD+17.40%
  • 1 year+20.49%
  • 3 years+14.61%/yr
  • 5 years+0.10%/yr
1Y volatility
22.33%
3Y volatility
19.43%
3Y Sharpe ratio
0.55

Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.

FMED top 10 holdings

All holdings →
#SymbolNameWeight
1TXG10X Genomics Inc4.56%
2TMOThermo Fisher Scientific Inc4.24%
3NTRANatera Inc4.20%
4DHRDanaher Corporation4.14%
5ILMNIllumina Inc3.62%
6LFSTLifestance Health Group Inc2.86%
7ARGXargenx NV ADR2.84%
8DIMSartorius Stedim Biotech SA2.78%
9RVMDRevolution Medicines Inc2.68%
10HTFLHeartflow, Inc. Common Stock2.42%

The top 10 holdings make up 34.3% of the fund (70 holdings in total). As of October 24, 2026.

FMED sector weights

Healthcare
100.0%

FMED region weights

North America
97.9%
Europe Developed
3.1%
United Kingdom
1.7%
Asia Emerging
0.7%

FMED asset allocation

U.S. stocks
88.4%
Cash
6.3%
Non-U.S. stocks
5.3%

FMED market-cap breakdown

Small cap
33.9%
Mid cap
31.5%
Large cap
16.3%
Micro cap
13.3%
Mega cap
1.0%

About Fidelity Disruptive Medicine ETF

The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.

FMED ETF FAQ

What is the FMED expense ratio?

Fidelity Disruptive Medicine ETF has a net expense ratio of 0.51%, or $51.00 a year for every $10,000 invested.

How much money is in FMED?

Fidelity Disruptive Medicine ETF has about $51.4M in net assets.

What are the top holdings of FMED?

The largest positions in FMED are 10X Genomics Inc (4.56%), Thermo Fisher Scientific Inc (4.24%), Natera Inc (4.20%). The fund holds 70 securities in total.

How has FMED performed?

FMED returned +20.49% over the past year and +0.10% a year over the past five years, including reinvested distributions.

Does FMED pay dividends?

FMED has a dividend yield of 0.00%.

When was FMED launched?

Fidelity Disruptive Medicine ETF began trading on April 16, 2020.